4-methylumbelliferone

from Wikipedia, the free encyclopedia
Structural formula
Structure of Hymecromon
General
Non-proprietary name Hymecromon
other names
  • 4-methylumbelliferone
  • β-methylumbelliferone
  • IUPAC : 7-Hydroxy-4-methylcoumarin
Molecular formula C 10 H 8 O 3
Brief description

white to yellowish crystals

External identifiers / databases
CAS number 90-33-5
EC number 201-986-7
ECHA InfoCard 100.001.806
PubChem 5280567
ChemSpider 4444190
DrugBank DB07118
Wikidata Q904431
Drug information
ATC code

A05 AX02

Drug class

Antispasmodic

properties
Molar mass 176.17 g · mol -1
Physical state

firmly

Melting point

194-195 ° C

pK s value

7.83

solubility
safety instructions
Please note the exemption from the labeling requirement for drugs, medical devices, cosmetics, food and animal feed
GHS labeling of hazardous substances
07 - Warning

Caution

H and P phrases H: 315-319-335
P: 261-305 + 351 + 338
Toxicological data

3850 mg kg −1 ( LD 50ratoral )

As far as possible and customary, SI units are used. Unless otherwise noted, the data given apply to standard conditions .

4-methylumbelliferone or hymecromone ( INN ) is a methyl - derivative of umbelliferone .

It is used as a medicinal substance (as a choleretic and musculotropic antispasmodic ) and as a light or sunscreen , as it absorbs UV radiation . It is also used in fluorescence analysis. It is often used in the form of esters , which are then cleaved by the esterases . Often used is 4-methylumbelliferyl heptanoate , which is abbreviated to MUH.

Trade names

Monopreparations

Cholspasmin (D), Chol-Spasmoletten (D), Unichol (A)

Individual evidence

  1. HPT Ammon (Ed.): Hunnius Pharmaceutical Dictionary . 9th edition. Walter de Gruyter, Berlin a. New York 2004, pp. 752-753.
  2. a b c d Entry on Hymecromon. In: Römpp Online . Georg Thieme Verlag, accessed on May 1, 2014.
  3. a b Data sheet 4-Methylumbelliferone from Sigma-Aldrich , accessed on April 4, 2011 ( PDF ).
  4. Data sheet HYMECROMONE CRS (PDF) at EDQM , accessed on July 31, 2008.
  5. Red List, as of August 2009.
  6. AGES-PharmMed, as of August 2009.